These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22243043)

  • 1. Statins to treat Alzheimer's disease: an incomplete story.
    Sabbagh MN; Sparks DL
    Expert Rev Neurother; 2012 Jan; 12(1):27-30. PubMed ID: 22243043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.
    Sparks DL; Connor DJ; Browne PJ; Lopez JE; Sabbagh MN
    J Nutr Health Aging; 2002; 6(5):324-31. PubMed ID: 12474023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
    Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
    Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of statins in Alzheimer's disease.
    Kandiah N; Feldman HH
    J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration.
    Pac-Soo C; Lloyd DG; Vizcaychipi MP; Ma D
    J Alzheimers Dis; 2011; 27(1):1-10. PubMed ID: 21734347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
    Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
    Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cholesterol and risk for late-onset Alzheimer's disease.
    Cedazo-Mínguez A; Ismail MA; Mateos L
    Expert Rev Neurother; 2011 Apr; 11(4):495-8. PubMed ID: 21469922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can statins prevent or help treat Alzheimer's disease?
    McGuinness B; Passmore P
    J Alzheimers Dis; 2010; 20(3):925-33. PubMed ID: 20182019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.
    Waters DD
    J Cardiol; 2010 Mar; 55(2):155-62. PubMed ID: 20206067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol and Alzheimer's disease--is there a relation?
    Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
    Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.
    Simons M; Schwärzler F; Lütjohann D; von Bergmann K; Beyreuther K; Dichgans J; Wormstall H; Hartmann T; Schulz JB
    Ann Neurol; 2002 Sep; 52(3):346-50. PubMed ID: 12205648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of statins: Alzheimer's disease?
    Patatanian E; Gales MA
    Consult Pharm; 2005 Aug; 20(8):663-73. PubMed ID: 16548662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyslipidemia and Dementia].
    Tamaoka A
    Brain Nerve; 2016 Jul; 68(7):737-42. PubMed ID: 27395458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.